Polish Journal of Pathology

Full text

1/2026 vol. 77
Original paper

Suppressing Dicer inhibits proliferation and contributes to cellular senescence, partially via a p21-associated senescence pathway

  1. Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

  2. Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan

  3. Department of Family Medicine, Leader Clinic, Taipei, Taiwan

  4. Division of Endocrinology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan

  5. Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Pol J Pathol 2026; 77 (1): 25-38

Data publikacji online: 2026/06/09
Article file
Suppressing Dicer.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review.JAMA 2024; 331: 425-435.
  2. Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am 2019; 48: 23-35.
  3. Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol (Lausanne) 2020; 11: 102.
  4. Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet 2023; 401: 1531-1544.
  5. Theotoki EI, Pantazopoulou VI, Georgiou S, Kakoulidis P, Filippa V, Stravopodis DJ, et al. Dicing the disease with Dicer: the implications of dicer ribonuclease in human pathologies. Int J Mol Sci 2020; 21: 7223.
  6. Szczyrek M, Grenda A, Kuznar-Kaminska B, Krawczyk P, Sawicki M, Batura-Gabryel H, et al. Methylation of DROSHA and DICER as a biomarker for the detection of lung cancer. Cancers (Basel) 2021; 13: 6139.
  7. Stratmann J, Wang CJ, Gnosa S, Wallin A, Hinselwood D, Sun XF, et al. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 2011; 11: 345.
  8. Tseng CF, Chen LT, Wang HD, Liu YH, Shiah SG. Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness. Cancer Sci 2022; 113: 1601-1612.
  9. Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, Lamont RJ, et al. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 2010; 49: 549-559.
  10. Meng L, Li H, Fu Y, Yu D, Tang J, Hu Y, et al. Somatic DICER1-mutant benign thyroid nodules in adults: a group of follicular nodular disease with continuous growth. J Clin Endocrinol Metab 2025; 110: 1559-1569.
  11. Lee YA, Im SW, Jung KC, Chung EJ, Shin CH, Kim JI, et al. Predominant DICER1 pathogenic variants in pediatric follicular thyroid carcinomas. Thyroid 2020; 30: 1120-1131.
  12. Ver Berne J, Van den Bruel A, Vermeire S, De Paepe P. DICER1 mutations define the landscape of poorly differentiated thyroid carcinoma in children and young adults: case report and literature review. Am J Surg Pathol 2024; 48: 1277-1283.
  13. Whaley RD, Gupta S, Manninen MC, O’Brien DR, Erickson LA. Clinicopathologic and molecular analysis of 15 pediatric and young adult patients with high-grade non-anaplastic thyroid carcinoma. Endocr Pathol 2024; 35: 397-410.
  14. Schiavo Lena M, Sanchez-Ares M, Brunetto E, Abdulkader- Nallib I, Maggiore R, Barbieri D, et al. Focal high-grade areas with a tumor-in-tumor pattern: another feature of pediatric DICER1-associated thyroid carcinoma? Endocr Pathol 2025; 36: 20.
  15. Cameselle-Teijeiro JM, Mete O, Asa SL, LiVolsi V. Inherited follicular epithelial-derived thyroid carcinomas: from molecular biology to histological correlates. Endocr Pathol 2021; 32: 77-101.
  16. Ramirez-Moya J, Wert-Lamas L, Riesco-Eizaguirre G, Santisteban P. Impaired microRNA processing by DICER1 down- regulation endows thyroid cancer with increased aggressiveness. Oncogene 2019; 38: 5486-5499.
  17. Penha RCC, Sepe R, De Martino M, Esposito F, Pellecchia S, Raia M, et al. Role of Dicer1 in thyroid cell proliferation and differentiation. Cell Cycle 2017; 16: 2282-2289.
  18. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
  19. Cheng CW, Fang WF, Tang KT, Lin JD. The pathogenic role of IFN-alpha in thyroiditis mouse models. Life Sci 2022; 288: 120172.
  20. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, Sharan R, et al. EXPANDER – an integrative program suite for microarray data analysis. BMC Bioinformatics 2005; 6: 232.
  21. Ke TW, Hsu HL, Wu YH, Chen WT, Cheng YW, Cheng CW. MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42. Dis Markers 2014; 2014: 617150.
  22. Cecchini MJ, Amiri M, Dick FA. Analysis of cell cycle position in mammalian cells. J Vis Exp 2012; 21: 3491.
  23. Shi JA, Lu DL, Huang X, Tan W. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164. Int J Mol Med 2014; 34: 237-243.
  24. Liao Z, Yeo HL, Wong SW, Zhao Y. Cellular senescence: mechanisms and therapeutic potential. Biomedicines 2021; 9: 1769.
  25. Hsu TW, Chen HA, Liao PH, Su YH, Chiu CF, Huang CY, et al. Dicer-mediated miR-200b expression contributes to cell migratory/ invasive abilities and cancer stem cells properties of breast cancer cells. Aging (Albany NY) 2022; 14: 6520-6536.
  26. Kommoss FKF, Chong AS, Chong AL, Pfaff E, Jones DTW, Hiemcke-Jiwa LS, et al. Genomic characterization of DICER1- associated neoplasms uncovers molecular classes. Nat Commun 2023; 14: 1677.
  27. Reyes-Castro RA, Chen SY, Seemann J, Kundu ST, Gibbons DL, Arur S. Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas. Sci Adv 2023; 9: eadf6210.
  28. Wojcik K, Krzeminska P, Kurzynska-Kokorniak A. Possible role of human ribonuclease dicer in the regulation of R loops. FEBS Open Bio 2025; 15: 1406-1418.
  29. Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, et al. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery 2014; 156: 1342-1350.
  30. Paulsson JO, Wang N, Gao J, Stenman A, Zedenius J, Mu N, et al. GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours. Endocr Relat Cancer 2020; 27: 295-308
  31. Frezzetti D, Reale C, Cali G, Nitsch L, Fagman H, Nilsson O, et al. The microRNA-processing enzyme Dicer is essential for thyroid function. PLoS One 2011; 6: e27648.
  32. Swahari V, Nakamura A, Deshmukh M. The paradox of dicer in cancer. Mol Cell Oncol 2016; 3: e1155006.
  33. Luan N, Mu Y, Mu J, Chen Y, Ye X, Zhou Q, et al. Dicer1 promotes colon cancer cell invasion and migration through modulation of tRF-20-MEJB5Y13 expression under hypoxia. Front Genet 2021; 12: 638244.
  34. Lai HH, Li JN, Wang MY, Huang HY, Croce CM, Sun HL, et al. HIF-1alpha promotes autophagic proteolysis of Dicer and enhances tumor metastasis. J Clin Invest 2018; 128: 625-643.
  35. Ibrahim AA, Schmithals C, Kowarz E, Koberle V, Kakoschky B, Pleli T, et al. Hypoxia causes downregulation of dicer in hepato- cellular carcinoma, which is required for upregulation of hypoxia-inducible factor 1alpha and epithelial-mesenchymal transition.Clin Cancer Res 2017; 23: 3896-3905.
  36. Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 2013; 13: 184-199.
  37. Derakhshani A, Rostami Z, Safarpour H, Shadbad MA, Nourbakhsh NS, Argentiero A, et al. From oncogenic signaling pathways to single-cell sequencing of immune cells: changing the landscape of cancer immunotherapy. Molecules 2021; 26: 2278.
  38. Ohtani N, Hara E. Roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci 2013; 104: 525-530.
Copyright: © 2026 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees